The World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo Ebola virus to its Emergency Use Listing. This move provides health responders in the Democratic Republic of the Congo (DRC) and Uganda a faster method to confirm infections using genetic material from blood samples, according to the WHO.
Why is the Bundibugyo Ebola test different from previous versions?
The Bundibugyo virus behaves differently than the more common Zaire strain. Because of these biological differences, existing treatments and diagnostics certified for Zaire do not automatically work for this specific strain, the WHO reported.
Older testing tools weren’t designed with the Bundibugyo strain in mind. The new molecular test allows for quicker and more reliable results by detecting the virus’s genetic material directly. This speed is critical for containment in high-risk zones.
What is the current status of the outbreak in DRC and Uganda?
The situation varies sharply by border. In the DRC, the outbreak is still expanding through Ituri Province. As of Thursday, the DRC recorded 1,406 laboratory-confirmed cases and 438 deaths, according to WHO data.
Uganda presents a contrast. No new cases have been reported there since June 21. Ugandan health officials attribute this progress to expanded treatment capacity and stronger contact tracing.
Comparative Outbreak Impact
| Region | Status | Confirmed Cases/Deaths |
|---|---|---|
| DRC (Ituri Province) | Expanding | 1,406 cases / 438 deaths |
| Uganda | Stable (No cases since June 21) | Not specified |
How are vaccines and treatments being developed?
There is currently no licensed vaccine or approved treatment specifically for the Bundibugyo virus. To address this gap, the WHO’s Strategic Advisory Group of Experts on Immunization has been reviewing candidate vaccines and therapeutics since late May.
Progress is moving into the clinical phase. A clinical trial testing two potential treatments enrolled its first patient this week, according to the WHO.
What challenges hinder contact tracing in Ituri Province?
The DRC faces logistical hurdles. Ituri Province is characterized by insecurity and large refugee populations. These factors, combined with heavy cross-border movement driven by trade and mining, make tracking the virus’s spread harder for health workers.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized that “no country alone can fight” these threats, citing hantavirus, Ebola, and Marburg as examples of why there is no alternative to international cooperation.
Frequently Asked Questions
No. According to the WHO, the Bundibugyo virus behaves differently enough that treatments developed for the Zaire strain do not automatically work.
What is the WHO Emergency Use Listing (EUL)?
The EUL is a process that evaluates a product’s quality, safety, and performance against international standards to get reliable tools into low- and middle-income countries quickly.
When was this outbreak declared a global emergency?
Dr. Tedros Adhanom Ghebreyesus declared the outbreak a public health emergency of international concern on May 17.
Want to stay updated on global health trends? Leave a comment below or subscribe to our newsletter for the latest verified reports on infectious disease breakthroughs.
